Response and Long-Term Outcome After Treatment With Third-Party Mesenchymal Stromal Cells - Updated Results In 58 Patients With Steroid-Refractory Acute Graft-Versus Host Disease »
02/24/14

NF-IoB Pathway Mutations Modulate Cell Survival and Ibrutinib Response In Chronic Lymphocytic Leukemia »
02/24/14

Prognostic Significance Of rs6773853 Susceptibility Locus In B-Cell Non-Hodgkina€™s Lymphoma »
02/24/14

Risk Factors For Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation From Matched Related Or Unrelated Donors »
02/24/14

Inhibition Of PI3K-I´ and -I3 Isoforms By IPI-145 In Chronic Lymphocytic Leukemia Overcomes Signals From PI3K/AKT/S6 Pathway and Promotes Apoptosis »
02/24/14

DNA Methylation Changes In Patients With Chronic Lymphocytic Leukemia Relapsing After Treatment Are Not Stochastic But Rather Selectively Affect Critical Pathways For B-Cell Physiology »
02/24/14

Functional Effects Of NOTCH1 Mutations In Chronic Lymphocytic Leukemia Patients »
02/24/14

First-In-Human Study Of AMG 319, a Highly Selective, Small Molecule Inhibitor Of PI3KI´, In Adult Patients With Relapsed Or Refractory Lymphoid Malignancies »
02/24/14

Lenalidomide Inhibits Proliferation Of Chronic Lymphocytic Leukemia Cells Via a Cereblon/p21WAF1/Cip1-Dependent Mechanism »
02/24/14

Phase II Trial Of Eltrombopag For Patients With Chronic Lymphocytic Leukemia (CLL) and Thrombocytopenia »
03/30/14